KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for late-breaking oral presentation and three for poster presentation at the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting taking place in Orlando, Florida from November 6–10, 2025.
The lake-breaking oral presentation will take place during Distinguished Industry & Late-breaking Oral Abstracts – Session 1 on Saturday, November 8, in room W230CD:
- Sebetralstat for On-demand Treatment of Hereditary Angioedema in Pediatric (2-11y) Patients: Interim Results from KONFIDENT-KID: Adil Adatia, Emel Aygören-Pürsün, Mauro Cancian, Aharon Kessel, H. Henry Li, Heloise Reumaux, H. James Wedner, Erik Hansen, Ya-Hsiu Chuang, Matthew Iverson, Michael D. Smith, Paul K. Audhya, Bob Geng.
- Presentation time: 5:33 pm ET
The three poster presentations will take place during ePosters – Meet the Authors: Session One on Friday, November 7, in West Hall E:
- Satisfaction with Sebetralstat for HAE Attacks in Patients Switching from Parenteral On-demand Treatments in KONFIDENT-S: Maeve E. O’Connor, Michael E. Manning, Inmaculada Martinez-Saguer, Sinisa Savic, Daniel F. Soteres, James Hao, Paolo Bajcic, Paul Audhya, Raffi Tachdjian.
- Presentation time: 3:05 pm ET
- A Delphi Consensus Study on the Barriers to On-Demand Treatment for Hereditary Angioedema Attacks: Aleena Banerji, Jonathan A. Bernstein, Paula J. Busse,Mauro Cancian, Danny M. Cohn, Timothy Craig, Michihiro Hide, William R. Lumry, Marc A. Riedl, Andrea Zanichelli.
- Presentation time: 4:20 pm ET
- Hereditary Angioedema Patient and Expert Physician Alignment on a Novel Oral On-demand Therapy: Raffi Tachdjian, John Andersen, William Lumry, Jonathan Bernstein, Maeve O’Connor, Henry Li, Joshua Jacobs, Michael Manning, Daniel Soteres.
- Presentation time: 5:35 pm ET
Full session details can be accessed on the ACAAI website. Links to all presentations will be available on the KalVista website under Publications on November 6, 2025.
